Aging
Conditions
Interventions
Treatment group:Policosanol Tablets 10 mg/tablet, 1 tablet nightly.
Control Group:Placebo
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
50 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 50 years; 2. Fully ambulatory with no severe organ dysfunction; 3. Has provided written informed consent.
Exclusion criteria
Exclusion criteria: 1. Limited mobility or bedridden; 2. Suffering from one or more age-related chronic diseases; 3. Low-density lipoprotein cholesterol > 3.9 mmol/L, triglycerides > 3.0 mmol/L; 4. Having severe organ dysfunction, malignant tumors, hematological disorders, cerebral hemorrhage, or other diseases of the circulatory, respiratory, or nervous systems; 5. Participation in another clinical drug trial within 1 month prior to enrollment; 6. Known or suspected history of allergy to the investigational drug or its excipients, or individuals with allergic constitution; 7. Patients unable to provide informed consent; 8. Patients whom the investigator deems unsuitable for participation due to potential protocol violations or other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biological age; | — |
Secondary
| Measure | Time frame |
|---|---|
| Comprehensive Geriatric Assessment;Improvement or progression of cardiovascular;Adverse reaction/event occurrence rate; | — |
Countries
China
Contacts
Public ContactPing Zhu
Chinese PLA General Hospital
Outcome results
None listed